05:08 PM EDT, 08/18/2025 (MT Newswires) -- Dennis Podlesak, Director, on August 14, 2025, sold 57,600 shares in Syndax Pharmaceuticals ( SNDX ) for $875,100. Following the Form 4 filing with the SEC, Podlesak has control over a total of 191,763 common shares of the company, with 191,763 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1395937/000095017025109815/xslF345X05/ownership.xml